Literature DB >> 24025048

Can high-risk fungicides be used in mixtures without selecting for fungicide resistance?

Alexey Mikaberidze, Bruce A McDonald, Sebastian Bonhoeffer.   

Abstract

Fungicide mixtures produced by the agrochemical industry often contain low-risk fungicides, to which fungal pathogens are fully sensitive, together with high-risk fungicides known to be prone to fungicide resistance. Can these mixtures provide adequate disease control while minimizing the risk for the development of resistance? We present a population dynamics model to address this question. We found that the fitness cost of resistance is a crucial parameter to determine the outcome of competition between the sensitive and resistant pathogen strains and to assess the usefulness of a mixture. If fitness costs are absent, then the use of the high-risk fungicide in a mixture selects for resistance and the fungicide eventually becomes nonfunctional. If there is a cost of resistance, then an optimal ratio of fungicides in the mixture can be found, at which selection for resistance is expected to vanish and the level of disease control can be optimized.

Mesh:

Substances:

Year:  2014        PMID: 24025048     DOI: 10.1094/PHYTO-07-13-0204-R

Source DB:  PubMed          Journal:  Phytopathology        ISSN: 0031-949X            Impact factor:   4.025


  3 in total

1.  Antimicrobial combinations: Bliss independence and Loewe additivity derived from mechanistic multi-hit models.

Authors:  Desiree Y Baeder; Guozhi Yu; Nathanaël Hozé; Jens Rolff; Roland R Regoes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

2.  Elevated Genetic Diversity in the Emerging Blueberry Pathogen Exobasidium maculosum.

Authors:  Jane E Stewart; Kyle Brooks; Phillip M Brannen; William O Cline; Marin T Brewer
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

3.  How large and diverse are field populations of fungal plant pathogens? The case of Zymoseptoria tritici.

Authors:  Bruce A McDonald; Frederic Suffert; Alessio Bernasconi; Alexey Mikaberidze
Journal:  Evol Appl       Date:  2022-07-15       Impact factor: 4.929

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.